Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank29
3Y CAGR-10.5%
5Y CAGR+22.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-10.5%/yr
Annual compound
5Y CAGR
+22.0%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -0.2% |
| 2024 | 0.02 | -40.4% |
| 2023 | 0.03 | +20.7% |
| 2022 | 0.03 | +14.9% |
| 2021 | 0.02 | +227.6% |
| 2020 | 0.01 | -97.1% |
| 2019 | 0.24 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.20 | -75.5% |
| 2016 | 0.84 | - |